KAIROS PHARMA LTD

Historical 13F Holders

Reported Value, Excluding Options

Total Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 48301N104 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Armistice Capital, LLC 13G/A	4.99%	884,938	13G/A	8/14/2025 Event 6/30/2025
Armistice Capital, LLC	4.99%	884,938
Steven Boyd	4.99%	884,938

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q2	14	968 k	$371 k	$0
2026 Q1	11	601 k	$342 k	$0
2025 Q4	14	856 k	$607 k	$0
2025 Q3	14	445 k	$506 k	$0
2025 Q2	11	219 k	$173 k	$0
2025 Q1	9	1.58 M	$1.46 M	$0
2024 Q4	6	407 k	$618 k	$0
2024 Q3	3	45.3 k	$70.0 k	$0